Total Payments
$322,158
2024 Payments
$8,755
Companies
21
Transactions
418
Medicare Patients
2,341
Medicare Billing
$651,028
Payment Breakdown by Category
Other$179,876 (55.8%)
Consulting$89,346 (27.7%)
Travel$41,587 (12.9%)
Food & Beverage$9,875 (3.1%)
Education$1,474 (0.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $116,316 | 54 | 36.1% |
| Consulting Fee | $89,346 | 40 | 27.7% |
| Honoraria | $63,560 | 45 | 19.7% |
| Travel and Lodging | $41,587 | 145 | 12.9% |
| Food and Beverage | $9,875 | 115 | 3.1% |
| Education | $1,474 | 19 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Fresenius USA Marketing, Inc. | $220,972 | 326 | $0 (2022) |
| GlaxoSmithKline, LLC. | $23,678 | 15 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $20,430 | 31 | $0 (2021) |
| AKEBIA THERAPEUTICS INC | $16,855 | 13 | $0 (2024) |
| Vifor Fresenius Medical Care Renal Pharma Ltd. | $12,297 | 9 | $0 (2020) |
| Aspire Bariatrics, Inc. | $6,000 | 2 | $0 (2018) |
| Rockwell Medical, Inc. | $5,475 | 2 | $0 (2019) |
| Otsuka America Pharmaceutical, Inc. | $4,165 | 3 | $0 (2021) |
| Lilly USA, LLC | $3,675 | 2 | $0 (2022) |
| Celgene Corporation | $2,866 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $8,755 | 10 | AKEBIA THERAPEUTICS INC ($8,755) |
| 2023 | $7,079 | 7 | GlaxoSmithKline, LLC. ($4,876) |
| 2022 | $21,496 | 13 | GlaxoSmithKline, LLC. ($10,193) |
| 2021 | $18,186 | 13 | AstraZeneca Pharmaceuticals LP ($4,876) |
| 2020 | $14,075 | 8 | Fresenius USA Marketing, Inc. ($5,361) |
| 2019 | $71,924 | 110 | Fresenius USA Marketing, Inc. ($52,223) |
| 2018 | $101,356 | 140 | Fresenius USA Marketing, Inc. ($87,727) |
| 2017 | $79,289 | 117 | Fresenius USA Marketing, Inc. ($70,948) |
All Payment Transactions
418 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Consulting Fee | Cash or cash equivalent | $7,350.00 | General |
| Category: Nephrology | ||||||
| 12/18/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Travel and Lodging | Cash or cash equivalent | $77.84 | General |
| Category: Nephrology | ||||||
| 12/18/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | Cash or cash equivalent | $29.50 | General |
| Category: Nephrology | ||||||
| 12/07/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $69.99 | General |
| Category: Nephrology | ||||||
| 12/07/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $54.98 | General |
| Category: Nephrology | ||||||
| 12/07/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $32.99 | General |
| Category: Nephrology | ||||||
| 12/07/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Nephrology | ||||||
| 12/06/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Travel and Lodging | In-kind items and services | $697.82 | General |
| Category: Nephrology | ||||||
| 12/06/2024 | AKEBIA THERAPEUTICS INC | Vafseo (Drug) | Travel and Lodging | In-kind items and services | $292.67 | General |
| Category: Nephrology | ||||||
| 10/23/2024 | AKEBIA THERAPEUTICS INC | Auryxia (Drug), Vafseo | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Nephrology | ||||||
| 06/13/2023 | Daiichi Sankyo Inc. | — | Consulting Fee | Cash or cash equivalent | $962.50 | General |
| 03/21/2023 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $2,098.99 | General |
| 03/21/2023 | GlaxoSmithKline, LLC. | — | Travel and Lodging | Cash or cash equivalent | $129.56 | General |
| 03/21/2023 | GlaxoSmithKline, LLC. | — | Food and Beverage | Cash or cash equivalent | $47.92 | General |
| 03/07/2023 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $650.00 | General |
| 01/17/2023 | Fresenius Kabi USA, LLC | — | Consulting Fee | Cash or cash equivalent | $1,240.00 | General |
| 01/03/2023 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| 11/29/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $3,250.00 | General |
| 11/09/2022 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,137.50 | General |
| 11/03/2022 | GlaxoSmithKline, LLC. | — | Food and Beverage | In-kind items and services | $120.02 | General |
| 10/04/2022 | Lilly USA, LLC | — | Consulting Fee | Cash or cash equivalent | $2,850.00 | General |
| 08/12/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/12/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Food and Beverage | In-kind items and services | $483.00 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/12/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Travel and Lodging | Cash or cash equivalent | $353.00 | General |
| Category: Phosphate binder for ESRD | ||||||
| 08/12/2022 | Fresenius USA Marketing, Inc. | Velphoro (Drug) | Travel and Lodging | Cash or cash equivalent | $293.00 | General |
| Category: Phosphate binder for ESRD | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 379 | 741 | $611,135 | $113,235 |
| 2022 | 15 | 577 | 1,193 | $883,295 | $166,295 |
| 2021 | 15 | 606 | 1,061 | $683,762 | $132,667 |
| 2020 | 17 | 779 | 1,756 | $1.5M | $238,832 |
Total Patients
2,341
Total Services
4,751
Medicare Billing
$651,028
Procedure Codes
56
All Medicare Procedures & Services
56 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2023 | 70 | 272 | $480,645 | $75,603 | 15.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 152 | 211 | $49,796 | $19,182 | 38.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 42 | 126 | $26,460 | $7,848 | 29.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 30 | $13,410 | $2,995 | 22.3% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2023 | 11 | 12 | $18,270 | $2,784 | 15.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 16 | 20 | $6,960 | $2,389 | 34.3% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 20 | 29 | $11,803 | $1,643 | 13.9% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 15 | 15 | $3,375 | $703.08 | 20.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 23 | 26 | $416.00 | $88.66 | 21.3% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 79 | 299 | $515,775 | $85,491 | 16.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 172 | 258 | $61,360 | $22,802 | 37.2% |
| 90966 | Home dialysis services per month (20 years or older) | Office | 2022 | 12 | 78 | $124,020 | $18,092 | 14.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 40 | 52 | $33,318 | $7,725 | 23.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 45 | 117 | $24,282 | $6,619 | 27.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 27 | 67 | $20,818 | $5,463 | 26.2% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 31 | 74 | $30,118 | $4,297 | 14.3% |
| 90945 | Dialysis procedure including 1 evaluation | Facility | 2022 | 11 | 59 | $22,789 | $4,077 | 17.9% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 12 | 14 | $20,790 | $3,332 | 16.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 21 | $7,308 | $3,041 | 41.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $9,369 | $2,724 | 29.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 15 | $7,599 | $1,610 | 21.2% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 14 | 15 | $3,375 | $607.78 | 18.0% |
| 81002 | Urinalysis, manual test | Office | 2022 | 71 | 88 | $1,408 | $299.99 | 21.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 11 | 14 | $966.00 | $115.09 | 11.9% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 81 | 202 | $348,450 | $58,314 | 16.7% |
About Dr. Daniel Coyne, MD
Dr. Daniel Coyne, MD is a Nephrology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1427074749.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Coyne, MD has received a total of $322,158 in payments from pharmaceutical and medical device companies, with $8,755 received in 2024. These payments were reported across 418 transactions from 21 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($116,316).
As a Medicare-enrolled provider, Coyne has provided services to 2,341 Medicare beneficiaries, totaling 4,751 services with total Medicare billing of $651,028. Data is available for 4 years (2020–2023), covering 56 distinct procedure/service records.
Ad
Practice Information
- Specialty Nephrology
- Location Saint Louis, MO
- Active Since 07/14/2006
- Last Updated 04/17/2025
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1427074749
Products in Payments
- Velphoro (Drug) $175,440
- Critline - Monitors (Device) $29,759
- Vafseo (Drug) $8,630
- LOKELMA (Drug) $8,329
- Velophoro (Drug) $6,950
- Not Product Related (Medical Supply) $6,805
- TRIFERIC (Drug) $5,475
- AspireAssist (Device) $3,000
- AspireAssist System (Device) $3,000
- Sotatercept (Drug) $2,866
- Auryxia (Drug) $2,250
- Venofer (Drug) $1,645
- JARDIANCE (Drug) $825.00
- Parsabiv (Biological) $108.27
- FARXIGA (Drug) $108.01
- Rituxan (Biological) $93.78
- Veltassa (Drug) $88.00
- ACTHAR (Biological) $74.99
- INVOKANA (Drug) $65.67
- Renal - Prismaflex System (Device) $19.91
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Saint Louis
Dr. Marcos Rothstein, Md, MD
Nephrology — Payments: $771,005
Nephrology $771,005
Dr. Tarek Alhamad, Md, MD
Nephrology — Payments: $237,080
Nephrology $237,080
Dr. Anuja Java, Md, MD
Nephrology — Payments: $162,504
Nephrology $162,504
Krista Lentine, Md,Phd, MD,PHD
Nephrology — Payments: $90,028
Nephrology $90,028
Dr. Tingting Li, Md, MD
Nephrology — Payments: $61,262
Nephrology $61,262
Dr. Thomas Nickolas, Md, MD
Nephrology — Payments: $48,074
Nephrology $48,074